Vineti creates innovative digital technology to drive the automation, production, and delivery of individualized medicines. The company combines leading software expertise with deep, first-hand industry experience in developing and commercializing personalized medicines to develop a cloud-based “platform of record” that ensures quality, scale, security, efficiency, traceability, and safety.
The Vineti platform provides actionable insights to continually optimize the cell and gene therapy process, accelerating time to revenue and decreasing costs. Caregivers and pharmaceutical pioneers are empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there’s an opportunity to provide greater health outcomes—and cures—to patients in need. Vineti supports a range of individualized therapies, including cell therapies, gene therapies, and personalized cancer vaccines, in clinical and commercial phases.
Vineti was co-founded by GE and the Mayo Clinic, and is 60 employees strong and growing. The company is based in San Francisco, California.